Details for New Drug Application (NDA): 203559
✉ Email this page to a colleague
The generic ingredient in PREDNISOLONE SODIUM PHOSPHATE is prednisolone sodium phosphate. There are eighty-eight drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.
Summary for 203559
| Tradename: | PREDNISOLONE SODIUM PHOSPHATE |
| Applicant: | Edenbridge Pharms |
| Ingredient: | prednisolone sodium phosphate |
| Patents: | 0 |
Pharmacology for NDA: 203559
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 203559
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PREDNISOLONE SODIUM PHOSPHATE | prednisolone sodium phosphate | SOLUTION;ORAL | 203559 | ANDA | ATLANTIC BIOLOGICALS CORP. | 17856-0815 | 17856-0815-1 | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0815-1) / 5 mL in 1 CUP, UNIT-DOSE |
| PREDNISOLONE SODIUM PHOSPHATE | prednisolone sodium phosphate | SOLUTION;ORAL | 203559 | ANDA | ATLANTIC BIOLOGICALS CORP. | 17856-0815 | 17856-0815-2 | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0815-2) / 10 mL in 1 CUP, UNIT-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | EQ 10MG BASE/5ML | ||||
| Approval Date: | Dec 20, 2016 | TE: | AA | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | EQ 20MG BASE/5ML | ||||
| Approval Date: | Dec 20, 2016 | TE: | AA | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | EQ 15MG BASE/5ML | ||||
| Approval Date: | Feb 6, 2023 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
